The Impact of Targeted Therapy on Intracranial Metastatic Disease Incidence and Survival
Intracranial metastatic disease (IMD) is a common and severe complication of primary cancers. Current treatment options for IMD include surgical resection and radiation therapy, although there has been recent interest in targeted therapy in the management of IMD. As of yet, insufficient data exist t...
Main Authors: | Anders W. Erickson, Sunit Das |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00797/full |
Similar Items
-
Clinical Biomarkers for Early Identification of Patients with Intracranial Metastatic Disease
by: Karolina Gaebe, et al.
Published: (2021-11-01) -
Editorial: Contemporary Management of Intracranial Metastatic Disease
by: Sunit Das, et al.
Published: (2019-08-01) -
Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review
by: Marin A. McDonald, et al.
Published: (2018-05-01) -
Management of Intracranial Metastatic Disease With Laser Interstitial Thermal Therapy
by: Afshin Salehi, et al.
Published: (2018-10-01) -
Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population
by: Shaoyan Lin, et al.
Published: (2021-05-01)